Alcon AG | ALC - Equity Capital And Reserves


Alcon AG reported $22.13B in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
AstraZeneca USD 50.3B 2.96B Jun/2026
Bayer EUR 28.85B 2.9B Mar/2026
Essilor EUR 39.22B 329M Jun/2026
Fresenius EUR 19.7B 766M Jun/2026
Fresenius Medical Care EUR 14.2B 13.95B Mar/2026
GlaxoSmithKline GBP 17.64B 223M Jun/2026
GRIFOLS EUR 7.98B 2.52B Jun/2026
Lonza CHF 9.13B 513M Dec/2025
Merck EUR 29.74B 1.15B Mar/2026
Novartis USD 41.95B 3.02B Jun/2026
Philips EUR 11.48B 84M Jun/2026
Roche Holding CHF 32.69B 1.11B Jun/2026
Sanofi EUR 69.57B 3.24B Jun/2026
Smith & Nephew USD 5.18B 356M Jun/2026
Sonova Holding CHF 2.66B 374.5M Jun/2025
UCB EUR 10.87B 1.18B Dec/2025